1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9896):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W009204S1
    Fmoc-Ala-OH-3,3,3-d3
    99.4%
    Fmoc-Ala-OH-3,3,3-d3 is the deuterium labeled Fmoc-Ala-OH-3,3,3.
    Fmoc-Ala-OH-3,3,3-d<sub>3</sub>
  • HY-13570BS1
    Betamethasone acetate-d5
    Betamethasone acetate-d5 is deuterium labeled Betamethasone acetate (HY-13570B). Betamethasone acetate is a glucocorticoid with prenatal application for preventing respiratory distress syndrome (RDS) in premature infants. Betamethasone acetate exhibits dose-dependent effects on somatic and brain development in offspring when administered prenatally to pregnant rats. Betamethasone acetate can be used for the study of antenatal intervention.
    Betamethasone acetate-d<sub>5</sub>
  • HY-W706319
    2-Amino-3-methyl-3H-imidazo[4,5-f]quinoline-d3
    2-Amino-3-methyl-3H-imidazo[4,5-f]quinoline-d3 is deuterium labeled 2-Ammo-3-memyl-imidazo-[4,5-f]-quinoIine. 2-Ammo-3-memyl-imidazo-[4,5-f]-quinoIine is a mutagenic compound.
    2-Amino-3-methyl-3H-imidazo[4,5-f]quinoline-d<sub>3</sub>
  • HY-W004051S
    1-Bromo-2-chlorobenzene-d4
    98.0%
    1-Bromo-2-chlorobenzene-d4 is the deuterium labeled 1-Bromo-2-chlorobenzene.
    1-Bromo-2-chlorobenzene-d<sub>4</sub>
  • HY-N7063S1
    Nerol-d6
    Nerol-d6 is deuterated labeled Nerol (HY-N7063). Nerol is a constituent of neroli oil. Nerol Nerol triggers mitochondrial dysfunction and induces apoptosis via elevation of Ca2+ and ROS. Antifungal activity.
    Nerol-d<sub>6</sub>
  • HY-130462S3
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d64
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d62 (POPC-d64) is deuterium labeled 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC. 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC (POPC), a phospholipid, is a major component of biological membranes. 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC is used for the preparation of liposomes and studying the properties of lipid bilayers.
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d64
  • HY-B0768S
    Lomerizine-d4
    Lomerizine-d4 is the deuterium labeled Lomerizine (HY-B0768). Lomerizine is an antagonist of L- and T-type voltagegated calcium channels.
    Lomerizine-d<sub>4</sub>
  • HY-18681S
    Voxelotor-d6
    Voxelotor-d6 (GBT 440-d6) is deuterium labeled Voxelotor. Voxelotor (GBT 440) is a potent inhibitor of haemoglobin S (HbS) polymerization. Voxelotor has the potential for sickle cell disease (SCD) treatment.
    Voxelotor-d<sub>6</sub>
  • HY-W017212S
    Methyl cinnamate-d7
    Methyl cinnamate-d7 is deuterated labeled Methyl cinnamate (HY-W017212). Methyl cinnamate (Methyl 3-phenylpropenoate), an active component of Zanthoxylum armatum, is a widely used natural flavor compound. Methyl cinnamate (Methyl 3-phenylpropenoate) possesses antimicrobial activity and is a tyrosinase inhibitor that can prevent food browning. Methyl cinnamate (Methyl 3-phenylpropenoate) has antiadipogenic activity through mechanisms mediated, in part, by the CaMKK2-AMPK signaling pathway.
    Methyl cinnamate-d<sub>7</sub>
  • HY-W654119
    CMPF-d3
    CMPF-d3 is the deuterium labeled CMPF-d3 (HY-W654119).
    CMPF-d<sub>3</sub>
  • HY-76251S3
    Etodolac-d4
    Etodolac-d4 (AY-24236-d4) is deuterium labeled Etodolac. Etodolac (AY-24236) is a non-steroidal anti-inflammatory compound that is a non-selective inhibitor of COX (IC50=53.5 nM)
    Etodolac-d<sub>4</sub>
  • HY-12789S
    Etrasimod-d9
    Etrasimod-d9 (APD334-d9) is a deuterium labeled Etrasimod (HY-12789). Etrasimod (APD334) is a potent, selective and orally available antagonist of the sphingosine-1-phosphate-1 (S1P1) receptor with an IC50 value of 1.88 nM in CHO cells..
    Etrasimod-d<sub>9</sub>
  • HY-W748320
    2,2',3,3',4,5,5',6,6'-Nonachloro-1,1'-biphenyl-13C12
    2,2',3,3',4,5,5',6,6'-Nonachloro-1,1'-biphenyl-13C12 is 13C labeled 2,2',3,3',4,5,5',6,6'-Nonachloro-1,1'-biphenyl.
    2,2',3,3',4,5,5',6,6'-Nonachloro-1,1'-biphenyl-<sup>13</sup>C<sub>12</sub>
  • HY-W011873S
    Palmitoleic acid-d14
    Palmitoleic acid-d14 is the deuterium labeled Palmitoleic acid. Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats.
    Palmitoleic acid-d<sub>14</sub>
  • HY-B0031S2
    Quetiapine-d8 fumarate
    Quetiapine-d8 (fumarate) is the deuterium labeled Quetiapine. Quetiapine is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor. Quetiapine is a dopamine receptor antagonist with a pIC50 of 6.33 for human D2 receptor. Quetiapine has moderate to high affinity for the human D2, HT1A, 5-HT2A, 5-HT2C receptor with pKis of 7.25, 5.74, 7.54, 5.55. Antidepressant and anxiolytic effects.
    Quetiapine-d<sub>8</sub> fumarate
  • HY-132690S1
    N-Demethyl Trimebutine-d3 hydrochloride
    N-Demethyl Trimebutine-d3 hydrochloride is deuterated labeled N-Demethyl Trimebutine.
    N-Demethyl Trimebutine-d<sub>3</sub> hydrochloride
  • HY-W750674
    Indole-3-carboxaldehyde-C13C8
    Indole-3-carboxaldehyde-13C8 (3-Formylindole-13C8) is the 13C-labeled Indole-3-carboxaldehyde (HY-W007376). Indole-3-carboxaldehyde, a banlangen extract, is the product of the oxidative degradation of indole-3-acetic acid (IAA) by crude enzyme preparations from etiolated pea seedlings. Indole-3-carboxaldehyde is a biochemical used to prepare analogs of the indole phytoalexin cyclobrassinin. Indole-3-carboxaldehyde also enhances the epithelial barrier and anti-inflammatory activity in the intestinal tract.
    Indole-3-carboxaldehyde-C<sup>13</sup>C<sub>8</sub>
  • HY-W751099
    Corticosterone-13C3
    Corticosterone-13C3 is a 13C-labeled corticosterone (HY-B1618). Corticosterone (17-Deoxycortisol) is an orally available glucocorticoid that can regulate limbic system neurons and has good immunosuppressive activity.
    Corticosterone-13C3
  • HY-W020044S
    DL-alpha-Tocopherol-13C3
    DL-alpha-Tocopherol-13C3 is the 13C-labeled DL-alpha-Tocopherol. DL-alpha-Tocopherol is a synthetic vitamin E, with antioxidation effect. DL-alpha-Tocopherol protects human skin fibroblasts against the cytotoxic effect of UVB.
    DL-alpha-Tocopherol-<sup>13</sup>C<sub>3</sub>
  • HY-W654353
    Tauro-α-muricholic acid-d4-1 sodium
    Tauro-α-muricholic acid-d4-1 (sodium) is deuterium labeled Tauro-α-muricholic acid (sodium). Tauro-α-muricholic acid (T-α-MCA) sodium is a FXR (Farnesoid X receptor) antagonist (IC50=28μM). Tauro-α-muricholic acid sodium is also a endogenous metabolite that can be found in cecal.
    Tauro-α-muricholic acid-d<sub>4</sub>-1 sodium